|
|
Line 1: |
Line 1: |
| | | |
| ==Structure of Pleiotrophin== | | ==Structure of Pleiotrophin== |
- | <StructureSection load='2n6f' size='340' side='right'caption='[[2n6f]], [[NMR_Ensembles_of_Models | 10 NMR models]]' scene=''> | + | <StructureSection load='2n6f' size='340' side='right'caption='[[2n6f]]' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[2n6f]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2N6F OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2N6F FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[2n6f]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2N6F OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2N6F FirstGlance]. <br> |
- | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">HBNF1, NEGF1, PTN ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2n6f FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2n6f OCA], [https://pdbe.org/2n6f PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2n6f RCSB], [https://www.ebi.ac.uk/pdbsum/2n6f PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2n6f ProSAT]</span></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2n6f FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2n6f OCA], [https://pdbe.org/2n6f PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2n6f RCSB], [https://www.ebi.ac.uk/pdbsum/2n6f PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2n6f ProSAT]</span></td></tr> | + | |
| </table> | | </table> |
| == Function == | | == Function == |
- | [[https://www.uniprot.org/uniprot/PTN_HUMAN PTN_HUMAN]] Secreted growth factor that induces neurite outgrowth and which is mitogenic for fibroblasts, epithelial, and endothelial cells. Binds anaplastic lymphoma kinase (ALK) which induces MAPK pathway activation, an important step in the anti-apoptotic signaling of PTN and regulation of cell proliferation.<ref>PMID:11278720</ref> <ref>PMID:1768439</ref>
| + | [https://www.uniprot.org/uniprot/PTN_HUMAN PTN_HUMAN] Secreted growth factor that induces neurite outgrowth and which is mitogenic for fibroblasts, epithelial, and endothelial cells. Binds anaplastic lymphoma kinase (ALK) which induces MAPK pathway activation, an important step in the anti-apoptotic signaling of PTN and regulation of cell proliferation.<ref>PMID:11278720</ref> <ref>PMID:1768439</ref> |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 22: |
Line 21: |
| __TOC__ | | __TOC__ |
| </StructureSection> | | </StructureSection> |
- | [[Category: Human]] | + | [[Category: Homo sapiens]] |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Ryan, E O]] | + | [[Category: Ryan EO]] |
- | [[Category: Shen, D]] | + | [[Category: Shen D]] |
- | [[Category: Wang, X]] | + | [[Category: Wang X]] |
- | [[Category: Angiogenesis]]
| + | |
- | [[Category: Cytokine]]
| + | |
- | [[Category: Glycosaminoglycan-binding protein]]
| + | |
- | [[Category: Heparin-binding protein]]
| + | |
- | [[Category: Mitogen]]
| + | |
| Structural highlights
Function
PTN_HUMAN Secreted growth factor that induces neurite outgrowth and which is mitogenic for fibroblasts, epithelial, and endothelial cells. Binds anaplastic lymphoma kinase (ALK) which induces MAPK pathway activation, an important step in the anti-apoptotic signaling of PTN and regulation of cell proliferation.[1] [2]
Publication Abstract from PubMed
Pleiotrophin (PTN) is a potent glycosaminoglycan-binding cytokine that is important in neural development, angiogenesis and tissue regeneration. Much of its activity is attributed to its interactions with the chondroitin sulfate (CS) proteoglycan, receptor type protein tyrosine phosphatase zeta (PTPRZ). However, there is little high resolution structural information on the interactions between PTN and CS, nor is it clear why the C-terminal tail of PTN is necessary for signaling through PTPRZ, even though it does not contribute to heparin binding. We determined the first structure of PTN and analyzed its interactions with CS. Our structure shows that PTN possesses large basic surfaces on both of its structured domains and also that residues in the hinge segment connecting the domains have significant contacts with the C-terminal domain. Our analysis of PTN-CS interactions showed that the C-terminal tail of PTN is essential for maintaining stable interactions with chondroitin sulfate A, the type of CS commonly found on PTPRZ. These results offer the first possible explanation of why truncated PTN missing the C-terminal tail is unable to signal through PTPRZ. NMR analysis of the interactions of PTN with CS revealed that the C-terminal domain and hinge of PTN make up the major CS-binding site in PTN, and that removal of the C-terminal tail weakened the affinity of the site for CSA but not for other high sulfation density CS. DATABASE: Coordinates of the ensemble of ten PTN structures have been deposited in RCSB under accession number 2n6f. Chemical shifts assignments and structural constraints have been deposited in BMRB under accession number 25762.
Structural studies reveal an important role for the pleiotrophin C-terminus in mediating interactions with chondroitin sulfate.,Ryan E, Shen D, Wang X FEBS J. 2016 Apr;283(8):1488-503. doi: 10.1111/febs.13686. Epub 2016 Mar 6. PMID:26896299[3]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Stoica GE, Kuo A, Aigner A, Sunitha I, Souttou B, Malerczyk C, Caughey DJ, Wen D, Karavanov A, Riegel AT, Wellstein A. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. J Biol Chem. 2001 May 18;276(20):16772-9. Epub 2001 Feb 8. PMID:11278720 doi:10.1074/jbc.M010660200
- ↑ Kretschmer PJ, Fairhurst JL, Decker MM, Chan CP, Gluzman Y, Bohlen P, Kovesdi I. Cloning, characterization and developmental regulation of two members of a novel human gene family of neurite outgrowth-promoting proteins. Growth Factors. 1991;5(2):99-114. PMID:1768439
- ↑ Ryan E, Shen D, Wang X. Structural studies reveal an important role for the pleiotrophin C-terminus in mediating interactions with chondroitin sulfate. FEBS J. 2016 Apr;283(8):1488-503. doi: 10.1111/febs.13686. Epub 2016 Mar 6. PMID:26896299 doi:http://dx.doi.org/10.1111/febs.13686
|